Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Panel Discussion
Calendar Export
Discussion led by Chairs
(ID 187)
Lecture Time
08:20 - 09:00
Session Name
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00